{"url_path":"/sec/cik-0002137777/8-k/2026-07-20/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/2137777/0001193125-26-309108-index.html","accession_number":"0001193125-26-309108","cik":"0002137777","ticker":null,"issuer_name":"Research Alliance Corp IV","edgar_url":"https://www.sec.gov/Archives/edgar/data/2137777/0001193125-26-309108-index.html","primary_entity_key":"0002137777","primary_entity_name":"Research Alliance Corp IV"},"word_count":205,"has_tables":true,"body_markdown":"Item 8.01. Other Events.\n\nOn July 14, 2026, Research Alliance Corporation IV (the “Company”) consummated its initial public offering (the “IPO”) of 7,500,000 Class A ordinary shares, par value $0.0001 per share (the “Public Shares”). The Public Shares were sold at an offering price of $10.00 per Public Share, generating gross proceeds of $75,000,000 (before underwriting discounts and commission and offering expenses).\n\nSimultaneously with the closing of the IPO, the Company consummated a private placement (the “Private Placement”) of an aggregate of 275,000 Class A ordinary shares (the “Private Placement Shares”) to Research Alliance Holdings IV LLC, the Company’s sponsor, at a purchase price of $10.00 per Private Placement Share, generating gross proceeds to the Company of $2,750,000.\n\nAs of July 14, 2026, a total of $75,000,000 of the net proceeds from the IPO and the Private Placement (including the underwriter’s deferred commission of $2,250,000) were deposited in a trust account established for the benefit of the Company’s public shareholders, with Continental Stock Transfer & Trust Company acting as trustee.\n\nAn audited balance sheet as of July 14, 2026 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement is included with this Current Report on Form 8-K as Exhibit 99.1."}